✦ LIBER ✦

JCOG trials of systemic chemotherapy for unresectable or recurrent gastric cancer

✍ Scribed by Narikazu Boku

Publisher: Springer
Year: 2009
Tongue: English
Weight: 224 KB
Volume: 12
Category: Article
ISSN: 1436-3291
DOI: 10.1007/s10120-008-0467-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term results for patients with unre

Long-term results for patients with unresectable gastric cancer who received chemotherapy in the Japan Clinical Oncology Group (JCOG) trials

✍ Masana Ohkuwa; Atsushi Ohtsu; Narikazu Boku; Shigeaki Yoshida; Yoshinori Miyata; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 89 KB

Phase II trial of S-1 for neoadjuvant ch

Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002)

✍ Taira Kinoshita; Mitsuru Sasako; Takeshi Sano; Hitoshi Katai; Hiroshi Furukawa; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 203 KB

Combination chemotherapy with irinotecan

Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer

✍ Shinya Ueda; Shuichi Hironaka; Narikazu Boku; Akira Fukutomi; Takayuki Yoshino; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 341 KB

A multicenter phase II study of biweekly

A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer

✍ Akihiro Nakajo; Shuichi Hokita; Sumiya Ishigami; Futoshi Miyazono; Tadaaki Etoh; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 299 KB

Phase 1 trial of combined chemotherapy a

Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer

✍ Sharon Spencer; Richard Wheeler; Glenn Peters; Ruby Meredith; Sam Beenken; Lisle 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Abstract ## Background. The management of recurrent unresectable head and neck cancer remains a challenging problem. Based on the circadian rhythm concept, we sought to determine the maximum tolerated dose (MTD) of infusional 5‐flourouracil (5‐FU), hydroxyurea (HU), and reirradiation (RT). ##

Weekly paclitaxel as second-line chemoth

Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer

✍ Shuichi Hironaka; Sadamoto Zenda; Narikazu Boku; Akira Fukutomi; Takayuki Yoshin 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 187 KB